Exploring drug repurposing for rare diseases through semantic analytics [SciBite + CCC webinar]

Rare diseases are defined in the US as conditions that affect fewer than 1 in 1500 people. By their very definition of serving a relatively small population of people, the cost of developing brand new drugs for this audience (or orphan drugs) can be prohibitively expensive.

During this 45-minute webinar, Michael Hughes, Head of Data Science brings his unique industry and technical experience as a bioinformatician and developer to explore:

• Expediting the process of drug repurposing
• How semantic analytics can be applied
• Developing treatments that are cost effective